Powder: -20°C for 3 years | In solvent: -80°C for 1 year
J-147 is an experimental drug with reported effects against both Alzheimer's disease and ageing in mouse models of accelerated aging. It is a curcumin derivative and a potent neurogenic and neuroprotective drug candidate initially developed for the treatment of neurodegenerative conditions associated with aging that impacts many pathways implicated in the pathogenesis of diabetic neuropathy.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 15,000 | |||
10 mg | 在庫あり | ¥ 21,500 | |||
25 mg | 在庫あり | ¥ 36,000 | |||
50 mg | 在庫あり | ¥ 53,500 | |||
100 mg | 在庫あり | ¥ 80,000 | |||
500 mg | 在庫あり | ¥ 188,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 16,500 |
説明 | J-147 is an experimental drug with reported effects against both Alzheimer's disease and ageing in mouse models of accelerated aging. It is a curcumin derivative and a potent neurogenic and neuroprotective drug candidate initially developed for the treatment of neurodegenerative conditions associated with aging that impacts many pathways implicated in the pathogenesis of diabetic neuropathy. |
ターゲット&IC50 | Neuroprotection:60-115 nM(EC50) |
別名 | J147 |
分子量 | 350.33 |
分子式 | C18H17F3N2O2 |
CAS No. | 1146963-51-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (128.45 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
J-147 1146963-51-0 Chromatin/Epigenetic GPCR/G Protein Neuroscience Monoamine Oxidase Dopamine Receptor Epigenetic Reader Domain oxidase dopamine brain disease MAO B Inhibitor SLC6A3 DAT J 147 blood neuroprotective inhibit MAO transporte monoamine Dopamine Transporter Alzheimer BBB barrier J147 inhibitor